Plante Moran Financial Advisors’s Concert Pharmaceuticals, Inc. CNCE Stock Holding History

Plante Moran Financial Advisors’s Portfolio CNCE Stock Details CNCE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-1,500	Closed	-$25K	–	869
2018 Q2	$25K	Buy	+1,500	New	+$29.1K	0.01%	449
2018 Q1	–	Sell	-2,000	Closed	-$52K	–	1022
2017 Q4	$52K	Buy	2,000 +1,000	+100%	+$20.1K	0.03%	343
2017 Q3	$15K	Hold	1,000	–	–	0.01%	499
2017 Q2	$14K	Sell	1,000 -500	-33%	-$7.37K	0.01%	521
2017 Q1	$26K	Sell	1,500 -500	-25%	-$6K	0.02%	437
2016 Q4	$21K	Hold	2,000	–	–	0.01%	479
2016 Q3	$20K	Buy	2,000 +500	+33%	+$5.46K	0.01%	495
2016 Q2	$17K	Buy	+1,500	New	+$19.1K	0.01%	458

Other funds holding CNCE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

ISL

Ingalls & Snyder LLC New York $2.83B AUM 21.61% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Plante Moran Financial Advisors's CNCE Position: Q3 2018 in Review

Plante Moran Financial Advisors sold out of Concert Pharmaceuticals, Inc. (CNCE) in Q3 2018, closing a stake of 1,500 shares — an estimated $25K sold.

Plante Moran Financial Advisors first reported a position in CNCE in Q2 2016 and held it in 8 quarters. The position peaked at $52K in Q4 2017. 111 funds tracked by Wall St. Rank hold CNCE as of Q3 2018.

Plante Moran Financial Advisors reported no remaining Concert Pharmaceuticals, Inc. position as of Q3 2018 after selling out during the quarter.
Plante Moran Financial Advisors sold 1,500 Concert Pharmaceuticals, Inc. shares in Q3 2018, an estimated $25K.
Plante Moran Financial Advisors first reported a position in Concert Pharmaceuticals, Inc. in Q2 2016 and held it in 8 quarters.
Plante Moran Financial Advisors's Concert Pharmaceuticals, Inc. position peaked at $52K in Q4 2017.
111 funds tracked by Wall St. Rank held Concert Pharmaceuticals, Inc. as of Q3 2018.

Based on Plante Moran Financial Advisors's 13F filing for Q3 2018, filed 9 Nov 2018.